Report Thumbnail
Product Code LP091290948B85
Published Date 2024/1/4
English155 PagesGlobal

Global Biobanking Market Growth (Status and Outlook) 2024-2030Pharmaceutical_LifeSciense Market


Report Thumbnail
Product Code LP091290948B85◆The Jan 2026 edition is also likely available. We will check with the publisher immediately.
Published Date 2024/1/4
English 155 PagesGlobal

Global Biobanking Market Growth (Status and Outlook) 2024-2030Pharmaceutical_LifeSciense Market



Abstract


Summary

According to our LPI (LP Information) latest study, the global Biobanking market size was valued at US$ 2871.2 million in 2023. With growing demand in downstream market, the Biobanking is forecast to a readjusted size of US$ 4658.3 million by 2030 with a CAGR of 7.2% during review period.
The research report highlights the growth potential of the global Biobanking market. Biobanking are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Biobanking. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Biobanking market.
Biobank is a biorepository for the preservation and collection of biological material used for diagnosis, biodiversity studies, and research. Depending on the aims of research, different biobanks store different kinds of samples such as tissues, blood, serum, DNA, and RNA.
Global Biobanking key players include Thermo Fisher, Beckman Coulter, Panasonic, etc. Global top three manufacturers hold a share over 15%.
United States is the largest market, with a share over 40%, followed by China, and Europe, both have a share about 50 percent.
In terms of product, Consumable is the largest segment, with a share about 55%. And in terms of application, the largest application is Population Biobanks, followed by Tissue Biobanks, Virtual Biobanks, etc.
Key Features:
The report on Biobanking market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Biobanking market. It may include historical data, market segmentation by Type (e.g., Equipment, Consumable), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Biobanking market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Biobanking market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Biobanking industry. This include advancements in Biobanking technology, Biobanking new entrants, Biobanking new investment, and other innovations that are shaping the future of Biobanking.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Biobanking market. It includes factors influencing customer ' purchasing decisions, preferences for Biobanking product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Biobanking market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Biobanking market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Biobanking market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Biobanking industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Biobanking market.
Market Segmentation:
Biobanking market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Equipment
Consumable
Segmentation by application
Virtual Biobanks
Tissue Biobanks
Population Biobanks
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher
Beckman Coulter
Panasonic
SOL Group
Promega
Merck
Greiner Bio One
Chart Industries
Brooks Life Science
Tecan Group
QIAGEN
BD
Lifeline Scientific
Hamilton
So-Low
TTP Labtech Ltd
Biolife Solutions
DNA Genotek
Custom Biogenic Systems
LVL Technologies
BioRep

Table of Contents

  • 1 Scope of the Report

    • 1.1 Market Introduction
    • 1.2 Years Considered
    • 1.3 Research Objectives
    • 1.4 Market Research Methodology
    • 1.5 Research Process and Data Source
    • 1.6 Economic Indicators
    • 1.7 Currency Considered
    • 1.8 Market Estimation Caveats
  • 2 Executive Summary

    • 2.1 World Market Overview
      • 2.1.1 Global Biobanking Market Size 2019-2030
      • 2.1.2 Biobanking Market Size CAGR by Region 2019 VS 2023 VS 2030
    • 2.2 Biobanking Segment by Type
      • 2.2.1 Equipment
      • 2.2.2 Consumable
    • 2.3 Biobanking Market Size by Type
      • 2.3.1 Biobanking Market Size CAGR by Type (2019 VS 2023 VS 2030)
      • 2.3.2 Global Biobanking Market Size Market Share by Type (2019-2024)
    • 2.4 Biobanking Segment by Application
      • 2.4.1 Virtual Biobanks
      • 2.4.2 Tissue Biobanks
      • 2.4.3 Population Biobanks
    • 2.5 Biobanking Market Size by Application
      • 2.5.1 Biobanking Market Size CAGR by Application (2019 VS 2023 VS 2030)
      • 2.5.2 Global Biobanking Market Size Market Share by Application (2019-2024)
  • 3 Biobanking Market Size by Player

    • 3.1 Biobanking Market Size Market Share by Players
      • 3.1.1 Global Biobanking Revenue by Players (2019-2024)
      • 3.1.2 Global Biobanking Revenue Market Share by Players (2019-2024)
    • 3.2 Global Biobanking Key Players Head office and Products Offered
    • 3.3 Market Concentration Rate Analysis
      • 3.3.1 Competition Landscape Analysis
      • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
    • 3.4 New Products and Potential Entrants
    • 3.5 Mergers & Acquisitions, Expansion
  • 4 Biobanking by Regions

    • 4.1 Biobanking Market Size by Regions (2019-2024)
    • 4.2 Americas Biobanking Market Size Growth (2019-2024)
    • 4.3 APAC Biobanking Market Size Growth (2019-2024)
    • 4.4 Europe Biobanking Market Size Growth (2019-2024)
    • 4.5 Middle East & Africa Biobanking Market Size Growth (2019-2024)
  • 5 Americas

    • 5.1 Americas Biobanking Market Size by Country (2019-2024)
    • 5.2 Americas Biobanking Market Size by Type (2019-2024)
    • 5.3 Americas Biobanking Market Size by Application (2019-2024)
    • 5.4 United States
    • 5.5 Canada
    • 5.6 Mexico
    • 5.7 Brazil
  • 6 APAC

    • 6.1 APAC Biobanking Market Size by Region (2019-2024)
    • 6.2 APAC Biobanking Market Size by Type (2019-2024)
    • 6.3 APAC Biobanking Market Size by Application (2019-2024)
    • 6.4 China
    • 6.5 Japan
    • 6.6 Korea
    • 6.7 Southeast Asia
    • 6.8 India
    • 6.9 Australia
  • 7 Europe

    • 7.1 Europe Biobanking by Country (2019-2024)
    • 7.2 Europe Biobanking Market Size by Type (2019-2024)
    • 7.3 Europe Biobanking Market Size by Application (2019-2024)
    • 7.4 Germany
    • 7.5 France
    • 7.6 UK
    • 7.7 Italy
    • 7.8 Russia
  • 8 Middle East & Africa

    • 8.1 Middle East & Africa Biobanking by Region (2019-2024)
    • 8.2 Middle East & Africa Biobanking Market Size by Type (2019-2024)
    • 8.3 Middle East & Africa Biobanking Market Size by Application (2019-2024)
    • 8.4 Egypt
    • 8.5 South Africa
    • 8.6 Israel
    • 8.7 Turkey
    • 8.8 GCC Countries
  • 9 Market Drivers, Challenges and Trends

    • 9.1 Market Drivers & Growth Opportunities
    • 9.2 Market Challenges & Risks
    • 9.3 Industry Trends
  • 10 Global Biobanking Market Forecast

    • 10.1 Global Biobanking Forecast by Regions (2025-2030)
      • 10.1.1 Global Biobanking Forecast by Regions (2025-2030)
      • 10.1.2 Americas Biobanking Forecast
      • 10.1.3 APAC Biobanking Forecast
      • 10.1.4 Europe Biobanking Forecast
      • 10.1.5 Middle East & Africa Biobanking Forecast
    • 10.2 Americas Biobanking Forecast by Country (2025-2030)
      • 10.2.1 United States Biobanking Market Forecast
      • 10.2.2 Canada Biobanking Market Forecast
      • 10.2.3 Mexico Biobanking Market Forecast
      • 10.2.4 Brazil Biobanking Market Forecast
    • 10.3 APAC Biobanking Forecast by Region (2025-2030)
      • 10.3.1 China Biobanking Market Forecast
      • 10.3.2 Japan Biobanking Market Forecast
      • 10.3.3 Korea Biobanking Market Forecast
      • 10.3.4 Southeast Asia Biobanking Market Forecast
      • 10.3.5 India Biobanking Market Forecast
      • 10.3.6 Australia Biobanking Market Forecast
    • 10.4 Europe Biobanking Forecast by Country (2025-2030)
      • 10.4.1 Germany Biobanking Market Forecast
      • 10.4.2 France Biobanking Market Forecast
      • 10.4.3 UK Biobanking Market Forecast
      • 10.4.4 Italy Biobanking Market Forecast
      • 10.4.5 Russia Biobanking Market Forecast
    • 10.5 Middle East & Africa Biobanking Forecast by Region (2025-2030)
      • 10.5.1 Egypt Biobanking Market Forecast
      • 10.5.2 South Africa Biobanking Market Forecast
      • 10.5.3 Israel Biobanking Market Forecast
      • 10.5.4 Turkey Biobanking Market Forecast
      • 10.5.5 GCC Countries Biobanking Market Forecast
    • 10.6 Global Biobanking Forecast by Type (2025-2030)
    • 10.7 Global Biobanking Forecast by Application (2025-2030)
  • 11 Key Players Analysis

    • 11.1 Thermo Fisher
      • 11.1.1 Thermo Fisher Company Information
      • 11.1.2 Thermo Fisher Biobanking Product Offered
      • 11.1.3 Thermo Fisher Biobanking Revenue, Gross Margin and Market Share (2019-2024)
      • 11.1.4 Thermo Fisher Main Business Overview
      • 11.1.5 Thermo Fisher Latest Developments
    • 11.2 Beckman Coulter
      • 11.2.1 Beckman Coulter Company Information
      • 11.2.2 Beckman Coulter Biobanking Product Offered
      • 11.2.3 Beckman Coulter Biobanking Revenue, Gross Margin and Market Share (2019-2024)
      • 11.2.4 Beckman Coulter Main Business Overview
      • 11.2.5 Beckman Coulter Latest Developments
    • 11.3 Panasonic
      • 11.3.1 Panasonic Company Information
      • 11.3.2 Panasonic Biobanking Product Offered
      • 11.3.3 Panasonic Biobanking Revenue, Gross Margin and Market Share (2019-2024)
      • 11.3.4 Panasonic Main Business Overview
      • 11.3.5 Panasonic Latest Developments
    • 11.4 SOL Group
      • 11.4.1 SOL Group Company Information
      • 11.4.2 SOL Group Biobanking Product Offered
      • 11.4.3 SOL Group Biobanking Revenue, Gross Margin and Market Share (2019-2024)
      • 11.4.4 SOL Group Main Business Overview
      • 11.4.5 SOL Group Latest Developments
    • 11.5 Promega
      • 11.5.1 Promega Company Information
      • 11.5.2 Promega Biobanking Product Offered
      • 11.5.3 Promega Biobanking Revenue, Gross Margin and Market Share (2019-2024)
      • 11.5.4 Promega Main Business Overview
      • 11.5.5 Promega Latest Developments
    • 11.6 Merck
      • 11.6.1 Merck Company Information
      • 11.6.2 Merck Biobanking Product Offered
      • 11.6.3 Merck Biobanking Revenue, Gross Margin and Market Share (2019-2024)
      • 11.6.4 Merck Main Business Overview
      • 11.6.5 Merck Latest Developments
    • 11.7 Greiner Bio One
      • 11.7.1 Greiner Bio One Company Information
      • 11.7.2 Greiner Bio One Biobanking Product Offered
      • 11.7.3 Greiner Bio One Biobanking Revenue, Gross Margin and Market Share (2019-2024)
      • 11.7.4 Greiner Bio One Main Business Overview
      • 11.7.5 Greiner Bio One Latest Developments
    • 11.8 Chart Industries
      • 11.8.1 Chart Industries Company Information
      • 11.8.2 Chart Industries Biobanking Product Offered
      • 11.8.3 Chart Industries Biobanking Revenue, Gross Margin and Market Share (2019-2024)
      • 11.8.4 Chart Industries Main Business Overview
      • 11.8.5 Chart Industries Latest Developments
    • 11.9 Brooks Life Science
      • 11.9.1 Brooks Life Science Company Information
      • 11.9.2 Brooks Life Science Biobanking Product Offered
      • 11.9.3 Brooks Life Science Biobanking Revenue, Gross Margin and Market Share (2019-2024)
      • 11.9.4 Brooks Life Science Main Business Overview
      • 11.9.5 Brooks Life Science Latest Developments
    • 11.10 Tecan Group
      • 11.10.1 Tecan Group Company Information
      • 11.10.2 Tecan Group Biobanking Product Offered
      • 11.10.3 Tecan Group Biobanking Revenue, Gross Margin and Market Share (2019-2024)
      • 11.10.4 Tecan Group Main Business Overview
      • 11.10.5 Tecan Group Latest Developments
    • 11.11 QIAGEN
      • 11.11.1 QIAGEN Company Information
      • 11.11.2 QIAGEN Biobanking Product Offered
      • 11.11.3 QIAGEN Biobanking Revenue, Gross Margin and Market Share (2019-2024)
      • 11.11.4 QIAGEN Main Business Overview
      • 11.11.5 QIAGEN Latest Developments
    • 11.12 BD
      • 11.12.1 BD Company Information
      • 11.12.2 BD Biobanking Product Offered
      • 11.12.3 BD Biobanking Revenue, Gross Margin and Market Share (2019-2024)
      • 11.12.4 BD Main Business Overview
      • 11.12.5 BD Latest Developments
    • 11.13 Lifeline Scientific
      • 11.13.1 Lifeline Scientific Company Information
      • 11.13.2 Lifeline Scientific Biobanking Product Offered
      • 11.13.3 Lifeline Scientific Biobanking Revenue, Gross Margin and Market Share (2019-2024)
      • 11.13.4 Lifeline Scientific Main Business Overview
      • 11.13.5 Lifeline Scientific Latest Developments
    • 11.14 Hamilton
      • 11.14.1 Hamilton Company Information
      • 11.14.2 Hamilton Biobanking Product Offered
      • 11.14.3 Hamilton Biobanking Revenue, Gross Margin and Market Share (2019-2024)
      • 11.14.4 Hamilton Main Business Overview
      • 11.14.5 Hamilton Latest Developments
    • 11.15 So-Low
      • 11.15.1 So-Low Company Information
      • 11.15.2 So-Low Biobanking Product Offered
      • 11.15.3 So-Low Biobanking Revenue, Gross Margin and Market Share (2019-2024)
      • 11.15.4 So-Low Main Business Overview
      • 11.15.5 So-Low Latest Developments
    • 11.16 TTP Labtech Ltd
      • 11.16.1 TTP Labtech Ltd Company Information
      • 11.16.2 TTP Labtech Ltd Biobanking Product Offered
      • 11.16.3 TTP Labtech Ltd Biobanking Revenue, Gross Margin and Market Share (2019-2024)
      • 11.16.4 TTP Labtech Ltd Main Business Overview
      • 11.16.5 TTP Labtech Ltd Latest Developments
    • 11.17 Biolife Solutions
      • 11.17.1 Biolife Solutions Company Information
      • 11.17.2 Biolife Solutions Biobanking Product Offered
      • 11.17.3 Biolife Solutions Biobanking Revenue, Gross Margin and Market Share (2019-2024)
      • 11.17.4 Biolife Solutions Main Business Overview
      • 11.17.5 Biolife Solutions Latest Developments
    • 11.18 DNA Genotek
      • 11.18.1 DNA Genotek Company Information
      • 11.18.2 DNA Genotek Biobanking Product Offered
      • 11.18.3 DNA Genotek Biobanking Revenue, Gross Margin and Market Share (2019-2024)
      • 11.18.4 DNA Genotek Main Business Overview
      • 11.18.5 DNA Genotek Latest Developments
    • 11.19 Custom Biogenic Systems
      • 11.19.1 Custom Biogenic Systems Company Information
      • 11.19.2 Custom Biogenic Systems Biobanking Product Offered
      • 11.19.3 Custom Biogenic Systems Biobanking Revenue, Gross Margin and Market Share (2019-2024)
      • 11.19.4 Custom Biogenic Systems Main Business Overview
      • 11.19.5 Custom Biogenic Systems Latest Developments
    • 11.20 LVL Technologies
      • 11.20.1 LVL Technologies Company Information
      • 11.20.2 LVL Technologies Biobanking Product Offered
      • 11.20.3 LVL Technologies Biobanking Revenue, Gross Margin and Market Share (2019-2024)
      • 11.20.4 LVL Technologies Main Business Overview
      • 11.20.5 LVL Technologies Latest Developments
    • 11.21 BioRep
      • 11.21.1 BioRep Company Information
      • 11.21.2 BioRep Biobanking Product Offered
      • 11.21.3 BioRep Biobanking Revenue, Gross Margin and Market Share (2019-2024)
      • 11.21.4 BioRep Main Business Overview
      • 11.21.5 BioRep Latest Developments
  • 12 Research Findings and Conclusion

USD 3,660 or Partial Purchase
*Prices are subject to change by the publisher.
© 2026 ShareFair Inc.